HEALTHSTREAM, INC.

(HSTM)
  Report
Delayed Nasdaq  -  05/17 04:00:00 pm EDT
19.33 USD   +0.47%
04/28HEALTHSTREAM INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
04/26TRANSCRIPT : HealthStream, Inc., Q1 2022 Earnings Call, Apr 26, 2022
CI
04/25HEALTHSTREAM : Announces First Quarter 2022 Results Page 1 - Form 8-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 881692832585--
Enterprise Value (EV)1 881692832585585585
P/E ratio 55,5x49,6x146x69,2x57,3x-
Yield ------
Capitalization / Revenue 3,47x2,83x3,24x2,16x2,02x1,84x
EV / Revenue 3,47x2,83x3,24x2,16x2,02x1,84x
EV / EBITDA 18,8x15,0x15,8x11,1x10,3x-
Price to Book 2,60x-----
Nbr of stocks (in thousands) 32 37831 67831 56230 392--
Reference price (USD) 27,221,826,419,219,219,2
Announcement Date 02/18/202002/22/202102/21/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 254245257270290317
EBITDA1 46,946,052,752,556,9-
Operating profit (EBIT)1 14,715,88,0611,713,922,2
Operating Margin 5,79%6,46%3,14%4,35%4,79%7,00%
Pre-Tax Profit (EBT)1 17,917,87,7711,313,9-
Net income1 15,814,15,858,5910,4-
Net margin 6,21%5,76%2,28%3,18%3,58%-
EPS2 0,490,440,180,280,34-
Dividend per Share ------
Announcement Date 02/18/202002/22/202102/21/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 64,164,365,466,368,270,3
EBITDA1 12,512,014,012,112,913,5
Operating profit (EBIT)1 1,79-0,464,041,952,593,17
Operating Margin 2,79%-0,71%6,17%2,94%3,79%4,52%
Pre-Tax Profit (EBT)1 1,69-0,503,761,902,543,14
Net income1 1,50-0,392,891,431,912,35
Net margin 2,34%-0,60%4,43%2,16%2,81%3,34%
EPS2 0,05-0,010,090,050,060,08
Dividend per Share ------
Announcement Date 10/25/202102/21/202204/25/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow 29,133,917,0---
ROE (Net Profit / Equities) 4,80%-----
Shareholders' equity1 329-----
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share 10,4-----
Cash Flow per Share ------
Capex 22,0-----
Capex / Sales 8,66%-----
Announcement Date 02/18/202002/22/202102/21/2022---
1 USD in Million
Previous periodNext period
Estimates
Key data
Capitalization (USD) 584 734 384
Net sales (USD) 256 712 000
Number of employees 1 088
Sales / Employee (USD) 235 949
Free-Float 78,9%
Free-Float capitalization (USD) 461 130 005
Avg. Exchange 20 sessions (USD) 2 414 663
Average Daily Capital Traded 0,41%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA